Benchmark Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$319K Hold
276
– – 0.25% 49
2026
Q2
$331K Sell
276
-20
-7% -$20.4K 0.27% 44
2026
Q1
$272K Hold
296
– – 0.24% 44
2025
Q4
$318K Buy
+296
New +$283K 0.32% 39

Other funds holding LLY

Benchmark Financial's LLY Position: Q3 2026 in Review

Benchmark Financial held its Eli Lilly (LLY) position steady in Q3 2026 at 276 shares worth $319K. The position accounts for 0.25% of the portfolio, ranked #49.

Benchmark Financial first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $331K in Q2 2026. 2,910 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Benchmark Financial held 276 shares of Eli Lilly worth $319K as of Q3 2026.
  • Benchmark Financial left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.25% of Benchmark Financial's portfolio in Q3 2026, its #49 holding.
  • Benchmark Financial first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Benchmark Financial's Eli Lilly position peaked at $331K in Q2 2026.
  • 2,910 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Benchmark Financial's 13F filing for Q3 2026, filed 16 Oct 2026.